In the case study, the predicted result for the KRAS-RAD50 gene pair aligned with the known labels, demonstrating the accurate predictive ability of MPASL for SL pairs and emphasizing the potential therapeutic significance of the predicted KRAS-RAD50 SL pair in cancer treatment. This evidence concerns the gene RAD50 and cancer.